The hospital lobby is asking federal officials to head off expanded data collection policies some drugmakers are implementing for providers participating in the 340B drug discount program.

The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more ...

A new report paints a stark picture of how a subset of large healthcare providers are drawing the lion’s share of 340B savings within a single state.  | A Minnesota analysis of providers' reported ...

A new Ohio bill won't expand the 340B program, but it will protect patients' ability to fill prescriptions at their pharmacy of choice.

AHA letter to the Health Resources and Services Administration about a new concerning development with the 340B Program.

Washingtonians are struggling to afford already high health care costs, and those costs keep climbing. Sadly, I’ve seen this ...

The 340B program requires pharmaceutical manufacturers to sell drugs at significant discounts — in some cases, extremely steep discounts — to hospitals and clinics serving large numbers of uninsured ...

Feds back AbbVie Colorado 340B fight, arguing state law conflicts with federal 340B program in a key 10th Circuit appeal.

The 340B Drug Pricing Program entitles participating hospitals and clinics (called covered entities) to purchase outpatient drugs at a substantial discount from manufacturers. Covered entities either ...

The drug discount program is under scrutiny on a variety of fronts ...

When it was passed in 1992, no one thought to mandate how hospitals and clinics would spend the deep discounts they receive on prescription drugs.

The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992, ...